Foley partner Kyle Faget, Health Care Practice Group Co-Chair and Chair of the Forum, and partner Monica Chmielewski will be speaking at the upcoming 4th Clinical Trial Agreements Forum on August 29.
On June 21, 2023, Xbrane announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Xbrane's supplemental Biologics License Application.
Foley and Lardner attorneys discuss new Food and Drug Administration guidance on decentralized clinical trials for medication and medical devices and its impacts with health care executive Jodi Akin in this Podcast.
Monica R. Chmielewski focuses her practice solely in representing health care providers and pharmaceutical and medical device companies in the area of health care, health care transactional work, clinical research and food and drug law.